Compare ABEO & CNDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEO | CNDT |
|---|---|---|
| Founded | 1974 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.0M | 258.4M |
| IPO Year | 1980 | N/A |
| Metric | ABEO | CNDT |
|---|---|---|
| Price | $5.09 | $1.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $18.20 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 03-19-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | $400,000.00 | ★ $3,072,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,589.77 | $5.56 |
| P/E Ratio | $4.03 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.93 | $1.64 |
| 52 Week High | $7.54 | $4.90 |
| Indicator | ABEO | CNDT |
|---|---|---|
| Relative Strength Index (RSI) | 46.51 | 32.67 |
| Support Level | $5.00 | $1.64 |
| Resistance Level | $5.41 | $1.81 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 14.33 | 5.43 |
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.